Overview

Effect of Tofacitinib in Treating ANCA-associated Vasculitis

Status:
Completed
Trial end date:
2021-01-31
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate the efficacy and safety of tofacitinib 5 mg twice daily in AAV patients.
Phase:
N/A
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Treatments:
Tofacitinib